WASHINGTON (AP) — Medicare to limit coverage for Aduhelm, an Alzheimer’s drug with questionable benefits that triggered a jump in premiums.
Copyright © 2024 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.